| Synonyms: | |
| Status: | Approved (2012) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | L01EA05 |
| UNII: | 4340891KFS |
| InChI Key | PHXJVRSECIGDHY-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C29H27F3N6O |
| Molecular Weight | 532.57 |
| AlogP | 4.46 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 65.77 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 39.0 |
| Primary Target | |
|---|---|
| ABL proto-oncogene 1, non-receptor tyrosine kinase |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | D015464 | ClinicalTrials |
| Gastrointestinal Stromal Tumors | 2 | D046152 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Thyroid Neoplasms | 2 | D013964 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| Adenocarcinoma of Lung | 2 | D000077192 | ClinicalTrials |
| Blast Crisis | 2 | D001752 | ClinicalTrials |
| Carcinoma, Medullary | 2 | D018276 | ClinicalTrials |
| Leukemia | 2 | D007938 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 943319-70-8 |
| ChEBI | 78543 |
| ChEMBL | CHEMBL1171837 |
| DrugBank | DB08901 |
| DrugCentral | 4716 |
| EPA CompTox | DTXSID50241426 |
| FDA SRS | 4340891KFS |
| Human Metabolome Database | HMDB0240214 |
| Guide to Pharmacology | 5890 |
| PDB | 0LI |
| PharmGKB | PA165980594 |
| PubChem | 24826799 |
| SureChEMBL | SCHEMBL589260 |
| ZINC | ZINC000036701290 |